Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish Population

Aboderin, 2002

Adams, 1993, Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial, Stroke, 24, 35, 10.1161/01.STR.24.1.35

Aiello, 2002, Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice, Arterioscler Thromb Vasc Biol, 22, 443, 10.1161/hq0302.105593

American Heart Association (2002) Heart disease and stroke statistics: 2003 update, Dallas

Chen, 1999, Fluorescence polarization in homogeneous nucleic acid analysis, Genome Res, 9, 492, 10.1101/gr.9.5.492

Danesh, 2000, Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses, BMJ, 321, 199, 10.1136/bmj.321.7255.199

Deary, 2004, The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947, J Pers Soc Psychol, 86, 130, 10.1037/0022-3514.86.1.130

Di Napoli, 2001, C-reactive protein in ischemic stroke: an independent prognostic factor, Stroke, 32, 917, 10.1161/01.STR.32.4.917

Dixon, 1990, Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis, Nature, 343, 282, 10.1038/343282a0

Duthie, 2002, Homocysteine, B vitamin status, and cognitive function in the elderly, Am J Clin Nutr, 75, 908, 10.1093/ajcn/75.5.908

Dwyer, 2004, Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis, N Engl J Med, 350, 29, 10.1056/NEJMoa025079

Falk, 1987, Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations, Ann Hum Genet, 51, 227, 10.1111/j.1469-1809.1987.tb00875.x

Gretarsdottir, 2003, The gene encoding phosphodiesterase 4D confers risk of ischemic stroke, Nat Genet, 35, 131, 10.1038/ng1245

Helgadottir, 2004, The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke, Nat Genet, 36, 233, 10.1038/ng1311

Helgason, 2001, mtDNA and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry, Am J Hum Genet, 68, 723, 10.1086/318785

Helgason, 2000, Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland, Am J Hum Genet, 67, 697, 10.1086/303046

Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323

Lusis, 2000, Atherosclerosis, Nature, 407, 233, 10.1038/35025203

MacLeod, 1999, No association between glu/asp polymorphism of NOS3 gene and ischemic stroke, Neurology, 53, 418, 10.1212/WNL.53.2.418

Mehrabian, 2002, Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice, Circ Res, 91, 120, 10.1161/01.RES.0000028008.99774.7F

Meiklejohn, 2001, Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke, Stroke, 32, 57, 10.1161/01.STR.32.1.57

Miller, 1990, Identification and isolation of a membrane protein necessary for leukotriene production, Nature, 343, 278, 10.1038/343278a0

Ridker, 1998, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women, Circulation, 98, 731, 10.1161/01.CIR.98.8.731

Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401

Spanbroek, 2003, Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis, Proc Natl Acad Sci USA, 100, 1238, 10.1073/pnas.242716099

Stefansson, 2003, Association of neuregulin 1 with schizophrenia confirmed in a Scottish population, Am J Hum Genet, 72, 83, 10.1086/345442

Terwilliger, 1992, A haplotype-based “haplotype relative risk” approach to detecting allelic associations, Hum Hered, 42, 337, 10.1159/000154096

Whalley, 2004, Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids, Am J Clin Nutr, 80, 1650, 10.1093/ajcn/80.6.1650